Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales Warning sheeba farhat6 Feb 2026 11:15 AM ISTNew Delhi: Novo Nordisk's shares tumbled on Wednesday, knocking nearly USD 50 billion in value from the Danish obesity drug giant, as it warned that...
Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India Parthika Patel5 Feb 2026 10:31 PM ISTNew Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo...
SURPASS-2- Tirzepatide vs Semaglutide in Type 2 Diabetes Deeksha Bhandari4 Feb 2026 12:30 PM ISTKey Summary: In addition to meeting the primary objective of noninferiority to semaglutide in type 2 diabetes (T2D), tirzepatide, at a dose of...
Cagrilintide-Semaglutide combo Improves Weight Loss and Glycemic Control in T2DM, finds trial Dr. Kamal Kant Kohli3 Feb 2026 8:45 PM ISTTopline results from the REIMAGINE 2 trial involving 2,728 adults with type 2 diabetes inadequately controlled on metformin showed that combined...
India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and Devices Susmita Roy29 Jan 2026 11:15 PM ISTNew Delhi: India's Free Trade Agreement (FTA) with the European Union is being projected as a major breakthrough for healthcare, with expectations of...
SURPASS-2: Superior HbA1c and Weight Reduction With Tirzepatide vs. Semaglutide Deeksha Bhandari29 Jan 2026 11:00 AM ISTThe SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already...
From Teriparatide to Pembrolizumab: CDSCO Clears Import of r-DNA Drugs via CT-18 Route Susmita Roy26 Jan 2026 1:58 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and December 2025 for...
Macleods Gets CDSCO Panel Nod to Conduct BE Studies for Semaglutide Prefilled Pens Susmita Roy25 Jan 2026 11:36 PM ISTNew Delhi: Accepting the toxicity data submitted by Macleods Pharmaceuticals, the Subject Expert Committee (SEC) functioning under the Central Drugs...
Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal sheeba farhat21 Jan 2026 7:01 PM ISTMumbai: Global pharmaceutical major Lupin Limited on Tuesday announced a licensing and supply agreement through its subsidiary Lupin Atlantis Holdings...
Novo Nordisk's Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity Treatment sheeba farhat17 Jan 2026 4:06 PM ISTThe authorisation for the drug, chemically known as semaglutide, covers only patients with a body mass index of 30 or higher using the drug for weight...
Once-Weekly Semaglutide Reduces Insulin Needs in Type 1 Diabetes, Suggests Study Medha Baranwal15 Jan 2026 10:15 AM ISTUSA: In a post hoc analysis of the ADJUST-T1D trial, adults with type 1 diabetes receiving once-weekly semaglutide 1 mg showed a significant reduction...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based ​on reports of such events observed with a variety of older medicines used or studied ‌for...
